SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Schauer-Maurer G, Erharter A, Holzner B, Muigg A, Hutterer M, Kindl T, Huber E, Perle V, Stockhammer G. J. Neurol. Neuroch. Psychiatr. 2009; 10(2): 36-42.

Copyright

(Copyright © 2009, Krause & Pachernegg)

DOI

unavailable

PMID

unavailable

Abstract

Psychosocial aspects and quality of life have become increasingly recognized in oncology over the last years. Patients with neurooncological diseases are burdened both with a life-threatening disease and cerebral deficits as a consequence of the disease itself or of necessary therapeutical interventions. Specific symptoms and psychosocial distress in neurooncological patients, as well as psychosocial interventions, including counselling, psychotherapy, psychopharmacologigal therapy and social work, are described in this article. It is critical to identify heavily distressed patients and their relatives. We show how to evaluate psychosocial distress implementing a computer-based evaluation of the quality of life in daily clinical routine. These data improve the interdisciplinary context for the integration of psychosocial interventions in neurooncology, help to minimize distress and improve the quality of life of neurooncological patients.


Language: de

Keywords

human; counseling; suicide; prognosis; quality of life; psychotherapy; depression; major depression; neurology; review; epilepsy; antidepressant agent; anxiolytic agent; neuroleptic agent; personality disorder; distress syndrome; cognitive defect; serotonin uptake inhibitor; quetiapine; social psychology; chronic disease; psychopharmacology; haloperidol; psychosocial care; olanzapine; risperidone; benzodiazepine; psychosomatic disorder; lorazepam; psychosocial disorder; flunitrazepam; zolpidem; symptom; social work; paranoid psychosis; medical examination; brain disease; triazolam; serotonin agonist; phobia; alpha adrenergic receptor stimulating agent; motor dysfunction; aphasia; disease activity; oxazepam; oncology; clinical evaluation; brotizolam; brain cancer; cinolazepam; melperone; prothipendyl; psychosocial distress

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print